Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

CeriBell (NASDAQ: CBLL) Stock Soars On Debut Trading: Here are Key Drivers

There are certain stocks that are expected to be in sharp focus this morning, and one of those is likely to be the CeriBell (NASDAQ: CBLL) stock, which delivered gains of 47% last Friday.

The News

The gains made by the stock came about after the company finally had its public listing through an IPO, which could generate proceeds of $180.3 million.

Last Thursday, the company priced its shares at $17 each, and that was a bigger price than the $14 to $16 a share range that had been estimated previously. The stock debuted on the NASDAQ the following day under the ticker symbol CBLL. As mentioned above, the stock performed strongly on its debut and ended the day at $25 a share.

Profitability

The company is not yet profitable. As per its S-1 filing last year, CeriBell suffered a loss of $29.5 million against revenues of $45.2 million in 2023. However, it should be noted that the company could be on the right trajectory, given its net loss narrowed from 2022 and revenues also moved in the positive direction.

The IPO market has not been particularly strong in recent years, and there have been very few of those in the medical technology space. However, as per a report from JP Morgan in April 2024, there had been stronger venture capital activity in the space.

Published by Jon Williams

Jon graduated from the University of Michigan with a degree in finance. He is an avid investor and enjoys reporting on the markets. When he is not in front of a computer he enjoys playing golf and watching basketball.

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
*By submitting your information you agree to the terms of our Privacy Policy. You will receive the DRP Journal newsletter, and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.